Singulair and Migranal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Singulair (montelukast sodium) and Migranal (dihydroergotamine mesylate). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Singulair and Migranal. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.

What is Migranal?

Migranal has active ingredients of dihydroergotamine mesylate. It is often used in migraine. eHealthMe is studying from 560 Migranal users. Check the latest studies of Migranal.



On Jul, 12, 2026

20 people who take Singulair and Migranal together, and have interactions are studied.

Singulair and Migranal drug interactions.

What are the common drug interactions of Singulair and Migranal, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Dyspnoea (difficult or laboured respiration)
  3. Insomnia (sleeplessness)
  4. Ocular toxicity (damages eye)
  5. Paranasal sinus hypersecretion
  6. Pyrexia (fever)
  7. Retinal dystrophy (progressive weakness and wasting of the retina)
  8. Retinopathy (acute damage to the retina of the eye)
  9. Stress
  10. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)

male:

n/a

What are the common drug interactions of Singulair and Migranal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anaphylactic reaction (serious allergic reaction)

20-29:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Sinusitis (inflammation of sinus)
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Facial pain
  6. Headache (pain in head)
  7. Paranasal sinus hypersecretion
  8. Pyrexia (fever)
  9. Anxiety
  10. Body temperature increased

30-39:

  1. Adjustment disorder
  2. Alopecia (absence of hair from areas of the body)
  3. Anxiety
  4. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  5. Brain neoplasm (tumour of brain)
  6. Candidiasis (candidiasis or thrush is a fungal infection)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Constipation
  9. Dependent personality disorder
  10. Depression

40-49:

  1. Accidental exposure
  2. Chest discomfort
  3. Chest pain
  4. Latex allergy
  5. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

50-59:

n/a

60+:

  1. Cataract (clouding of the lens inside the eye)
  2. Drug ineffective
  3. Scar
  4. Ocular toxicity (damages eye)
  5. Retinal dystrophy (progressive weakness and wasting of the retina)
  6. Retinopathy (acute damage to the retina of the eye)
  7. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
  8. Blood creatinine increased
  9. Injection site pain
  10. Laryngeal haemorrhage (bleeding from larynx)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 15.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  3. Urinary Tract Infection: 2 people, 10.00%
  4. Irritable Bowel Syndrome: 2 people, 10.00%
  5. Bladder Pain: 2 people, 10.00%
  6. Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 10.00%
  7. Food Allergy: 2 people, 10.00%
  8. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 10.00%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%
  10. Menopause (end of monthly cycles in women): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Singulair and Migranal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Singulair and Migranal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Migranal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Migranal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium and dihydroergotamine mesylate (the active ingredients of Singulair and Migranal, respectively), and Singulair and Migranal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: